心臓安全サービスの市場：サービスタイプ、種類、エンドユーザー別-2025-2030年の世界予測

心臓安全サービス市場は、2023年に12億2,000万米ドルと評価され、2024年には13億4,000万米ドルに達すると予測され、CAGR 10.91％で成長し、2030年には25億2,000万米ドルになると予測されています。

心臓安全サービスは、医薬品化合物、特に新薬が心臓の機能に悪影響を及ぼさないように設計された、さまざまな評価とモニタリングのプロセスを包含します。これらのサービスは、主に前臨床試験中の医薬品開発段階において、規制遵守を確実にし、患者の安全を守るために極めて重要です。その用途は、製薬、バイオテクノロジー、CRO（医薬品開発業務受託機関）など、最終用途の幅広い業界に及んでいます。心臓安全サービスの必要性は、FDAやEMAのような、医薬品の上市を承認する前に包括的な心臓スクリーニングを必要とする機関の厳しい規制義務によって推進されています。市場は、心血管疾患の有病率の増加、患者の安全性への関心の高まり、医薬品開発の複雑化などの影響を大きく受けています。臨床試験活動やバイオシミラー医薬品の発売の急増が、こうしたサービスの需要をさらに押し上げています。主な成長促進要因には、心臓安全性評価の効率と精度を高める画像処理・解析技術の進歩があります。しかし、運用コストの高さ、規制上の課題、複雑な心臓データの解釈に習熟した専門家の必要性などの制約があります。人工知能と機械学習の統合には新たな機会が存在し、心臓安全性プロトコルの合理化とヒューマンエラーの低減を目指しています。企業は、個々の患者のニーズに対応するリアルタイムモニタリング技術や個別化医療アプローチの開発に投資することが推奨されます。新興諸国へのサービス拡大には特筆すべき可能性があります。業界が成長志向を維持する一方で、企業は規制の進化や市場プレイヤーの統合といった課題を乗り越えなければならないです。診断法の革新と技術パートナーとの協力に注力することで、この進化する市場情勢において競争優位に立つことができると思われます。

市場力学：急速に進化する心臓安全サービス市場の主要市場インサイトを公開

心臓安全サービス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心血管疾患の罹患率の上昇と効果的かつ安全な治療の必要性
  • 心毒性または心血管リスクを検出するためのバイオシミラーおよびバイオマーカーの使用
  • 循環器領域における個別化治療を奨励する政府の取り組み
• 市場抑制要因
  • 心臓評価サービスの比較的高いコストと熟練した専門家の限られた利用可能性
• 市場機会
  • 心臓安全性試験およびモニタリングシステムの進歩
  • 心臓治療の臨床試験と研究開発の増加
• 市場の課題
  • 各国における規制の標準化の欠如

ポーターの5つの力：心臓安全サービス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓安全サービス市場における外部からの影響の把握

外部マクロ環境要因は、心臓安全サービス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓安全サービス市場における競合情勢の把握

心臓安全サービス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓安全サービス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓安全サービス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限はベンダーを明確かつ正確に区分し、ユーザーが戦略目標に最適なパートナーやソリューションを特定するのに役立ちます。

本レポートは、主要な注目分野を網羅した包括的な市場分析を提供しています：

1.市場の浸透度：業界主要企業の広範なデータを含む、現在の市場環境の詳細なレビュー。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 心血管疾患の発生率の上昇と効果的かつ安全な治療の必要性
    • 心毒性または心血管リスクを検出するためのバイオシミラーとバイオマーカーの使用
    • 心臓病学における個別化治療を奨励する政府の取り組み
  • 抑制要因
    • 心臓評価サービスのコストが比較的高く、熟練した専門家が不足している
  • 機会
    • 心臓安全性検査およびモニタリングシステムの進歩
    • 心臓治療に関する臨床試験と研究開発の増加
  • 課題
    • 各国における規制の標準化の欠如
• 市場セグメンテーション分析
  • サービスタイプ：効率的な心血管画像診断サービスに対するニーズの高まり
  • タイプ：医薬品開発における統合心臓安全サービスの利用拡大
  • エンドユーザー：製薬会社およびバイオ製薬会社による心臓安全サービスの採用が急増
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境
• 顧客のカスタマイズ

第6章 心臓安全サービスの市場：サービスタイプ別

• 血圧測定サービス
• 心臓血管画像診断サービス
• ECGまたはホルター測定サービス
• 徹底的なQT研究

第7章 心臓安全サービスの市場：タイプ別

• 統合サービス
• スタンドアロンサービス

第8章 心臓安全サービスの市場：エンドユーザー別

• 契約調査機関
• 製薬・バイオ医薬品企業

第9章 南北アメリカの心臓安全サービスの市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心臓安全サービスの市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心臓安全サービスの市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • OSFヘルスケアはベリンヘルスと提携し、デルタ郡の心臓血管サービスを拡大
  • Jubilant RadiopharmaとCardiac Imaging, Inc.がモバイル心臓PETサービスへのアクセス拡大に向けた独占提携を発表
  • GEヘルスケア、心臓血管疾患患者向けVscan Air SLデバイスを発表
  • ClarioとAliveCorが協力し、分散型臨床試験のモニタリング向けに、試験に特化した高度な6誘導ECGソリューションを提供
  • メトリオン・バイオサイエンス、GLP hERGスクリーニングサービスの開始を発表
  • ハートネットがテレカーディオロジー製品 ASAANを発売
  • AliveCorとLusciiが「Heart Clinic In a Box」で提携
  • アボット、世界初のデュアルチャンバーリードレスペースメーカーのFDA承認を取得
  • フィリップスとバイオトロニックが提携し、院外心臓病研究室のケアを拡大
  • アボット、カーディオバスキュラー・システムの8億9,000万米ドルの買収を完了
  • フィリップスとトライヘルス、ベセスダ北病院キャンパス内の新しいトライヘルス心臓血管研究所の中心で複数年にわたるパートナーシップを発表
  • バヌークグループ、米国オフィス開設で世界展開を継続

企業一覧

• Lunit Inc.
• NEXEL Co., Ltd.
• Tempus Labs, Inc.
• Certara, Inc.
• Toray Medical Company Limited by Toray Industries
• Metrion Biosciences Limited
• Circle Cardiovascular Imaging Inc.
• Medpace, Inc.
• Butterfly Network Inc.
• GE HealthCare Technologies Inc.
• Ncardia Services B.V.
• Shanghai Medicilon Inc.
• Thermo Fisher Scientific Inc.
• Octagos Health, Inc.
• Richmond Pharmacology Limited
• Banook Group
• IQVIA Holdings Inc.
• Abbott Laboratories
• Koninklijke Philips N.V.
• Clario
• Siemens Healthcare GmbH
• PhysioStim SAS
• Biotrial
• MERIT CRO, Inc.
• Dozee
• AliveCor, Inc.
• Laboratory Corporation of America Holdings
• Clyde Biosciences Limited
• Eurofins Scientific SE
• ICON PLC
• Celerion

LIST OF FIGURES

• FIGURE 1. CARDIAC SAFETY SERVICES MARKET RESEARCH PROCESS
• FIGURE 2. CARDIAC SAFETY SERVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIAC SAFETY SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIAC SAFETY SERVICES MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY BLOOD PRESSURE MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CARDIOVASCULAR IMAGING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY ECG OR HOLTER MEASUREMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY THOROUGH QT STUDIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY INTEGRATED SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY STANDALONE SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIAC SAFETY SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 29. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CARDIAC SAFETY SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 46. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 49. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 113. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 116. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM CARDIAC SAFETY SERVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. CARDIAC SAFETY SERVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. CARDIAC SAFETY SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiac Safety Services Market was valued at USD 1.22 billion in 2023, expected to reach USD 1.34 billion in 2024, and is projected to grow at a CAGR of 10.91%, to USD 2.52 billion by 2030.

Cardiac Safety Services encompass a range of assessments and monitoring processes designed to ensure that pharmaceutical compounds, especially new drugs, do not adversely affect the heart's function. These services are crucial in drug development phases, primarily during preclinical trials, to ensure regulatory compliance and protect patient safety. Their application spans a wide range of end-use industries, including pharmaceuticals, biotechnology, and CROs (Contract Research Organizations). The necessity of cardiac safety services is driven by stringent regulatory mandates from bodies like the FDA and EMA, which require comprehensive cardiac screening before a drug can be approved for market release. The market is heavily influenced by the increasing prevalence of cardiovascular diseases, heightened focus on patient safety, and the growing complexities of drug development. A surge in clinical trial activities and biosimilar launches further propels the demand for these services. Key growth drivers include advancements in imaging and analytics technology, enhancing the efficiency and accuracy of cardiac safety assessments. However, the market faces limitations such as high operational costs, regulatory challenges, and the need for skilled professionals proficient in interpreting complex cardiac data. Emerging opportunities exist in the integration of artificial intelligence and machine learning, aiming to streamline cardiac safety protocols and reduce human error. Businesses are recommended to invest in developing real-time monitoring technologies and personalized medicine approaches, catering to individual patient needs. There's a notable potential in expanding services to developing countries, where the market penetration of cardiac safety services is still low. While the industry remains growth-oriented, companies must navigate challenges such as evolving regulations and the consolidation of market players. A focus on innovation in diagnostic methods and collaboration with technological partners will provide a competitive edge in this evolving market landscape.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Safety Services Market

The Cardiac Safety Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidence of cardiovascular disorders and the need for effective & safe treatment
  • Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
  • Government initiatives encouraging personalized treatments in cardiology
• Market Restraints
  • Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
• Market Opportunities
  • Advancements in cardiac safety testing and monitoring systems
  • Growing number of clinical trials and R&D for cardiac treatments
• Market Challenges
  • Lack of regulatory standardization across various countries

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Safety Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Safety Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Safety Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Safety Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Safety Services Market

A detailed market share analysis in the Cardiac Safety Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Safety Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Safety Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Safety Services Market, highlighting leading vendors and their innovative profiles. These include Lunit Inc., NEXEL Co., Ltd., Tempus Labs, Inc., Certara, Inc., Toray Medical Company Limited by Toray Industries, Metrion Biosciences Limited, Circle Cardiovascular Imaging Inc., Medpace, Inc., Butterfly Network Inc., GE HealthCare Technologies Inc., Ncardia Services B.V., Shanghai Medicilon Inc., Thermo Fisher Scientific Inc., Octagos Health, Inc., Richmond Pharmacology Limited, Banook Group, IQVIA Holdings Inc., Abbott Laboratories, Koninklijke Philips N.V., Clario, Siemens Healthcare GmbH, PhysioStim SAS, Biotrial, MERIT CRO, Inc., Dozee, AliveCor, Inc., Laboratory Corporation of America Holdings, Clyde Biosciences Limited, Eurofins Scientific SE, ICON PLC, and Celerion.

Market Segmentation & Coverage

This research report categorizes the Cardiac Safety Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Service Type, market is studied across Blood Pressure Measurement Services, Cardiovascular Imaging Services, ECG or Holter Measurement Services, and Thorough QT Studies.
• Based on Type, market is studied across Integrated Services and Standalone Services.
• Based on End-User, market is studied across Contract Research Organizations and Pharmaceutical & Biopharmaceutical Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidence of cardiovascular disorders and the need for effective & safe treatment
    • 5.1.1.2. Use of biosimilars and biomarkers to detect cardiotoxicity or cardiovascular risks
    • 5.1.1.3. Government initiatives encouraging personalized treatments in cardiology
  • 5.1.2. Restraints
    • 5.1.2.1. Relatively high cost of cardiac evaluation services and limited availability of skilled professionals
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in cardiac safety testing and monitoring systems
    • 5.1.3.2. Growing number of clinical trials and R&D for cardiac treatments
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of regulatory standardization across various countries
• 5.2. Market Segmentation Analysis
  • 5.2.1. Service Type: Proliferating need for efficient cardiovascular imaging services
  • 5.2.2. Type: Expanding use of integrated cardiac safety services for drug development
  • 5.2.3. End-User: Surging adoption of cardiac safety services by pharmaceutical & biopharmaceutical companies
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Cardiac Safety Services Market, by Service Type

• 6.1. Introduction
• 6.2. Blood Pressure Measurement Services
• 6.3. Cardiovascular Imaging Services
• 6.4. ECG or Holter Measurement Services
• 6.5. Thorough QT Studies

7. Cardiac Safety Services Market, by Type

• 7.1. Introduction
• 7.2. Integrated Services
• 7.3. Standalone Services

8. Cardiac Safety Services Market, by End-User

• 8.1. Introduction
• 8.2. Contract Research Organizations
• 8.3. Pharmaceutical & Biopharmaceutical Companies

9. Americas Cardiac Safety Services Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiac Safety Services Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Safety Services Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. OSF HealthCare Establishes a Partnership with Bellin Health to Expand Cardiovascular Services in Delta County
  • 12.3.2. Jubilant Radiopharma and Cardiac Imaging, Inc. Announce Exclusive Partnership to Expand Access for Mobile Cardiac PET Offering
  • 12.3.3. GE HealthCare Announces Vscan Air SL Device for Cardiac, Vascular Patients
  • 12.3.4. Clario and AliveCor Collaborate to Offer Advanced, Trial-Focused Six-Lead ECG Solutions for Monitoring in Decentralized Clinical Trials
  • 12.3.5. Metrion Biosciences Announces Launch of Good Laboratory Practice (GLP) hERG Screening Service
  • 12.3.6. Heartnet Launches Telecardiology Product ASAAN
  • 12.3.7. AliveCor, Luscii Partner On 'Heart Clinic In a Box'
  • 12.3.8. Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker
  • 12.3.9. Philips, Biotronik Partner to Expand Care for Out-of-Hospital Cardiology Labs
  • 12.3.10. Abbott Completes USD 890 Million Acquisition of Cardiovascular Systems
  • 12.3.11. Philips and TriHealth Announce Multi-Year Partnership at Heart of New Trihealth Heart & Vascular Institute on the Campus of Bethesda North Hospital
  • 12.3.12. Banook Group Continues Global Expansion with the U.S. Office Opening

Companies Mentioned

• 1. Lunit Inc.
• 2. NEXEL Co., Ltd.
• 3. Tempus Labs, Inc.
• 4. Certara, Inc.
• 5. Toray Medical Company Limited by Toray Industries
• 6. Metrion Biosciences Limited
• 7. Circle Cardiovascular Imaging Inc.
• 8. Medpace, Inc.
• 9. Butterfly Network Inc.
• 10. GE HealthCare Technologies Inc.
• 11. Ncardia Services B.V.
• 12. Shanghai Medicilon Inc.
• 13. Thermo Fisher Scientific Inc.
• 14. Octagos Health, Inc.
• 15. Richmond Pharmacology Limited
• 16. Banook Group
• 17. IQVIA Holdings Inc.
• 18. Abbott Laboratories
• 19. Koninklijke Philips N.V.
• 20. Clario
• 21. Siemens Healthcare GmbH
• 22. PhysioStim SAS
• 23. Biotrial
• 24. MERIT CRO, Inc.
• 25. Dozee
• 26. AliveCor, Inc.
• 27. Laboratory Corporation of America Holdings
• 28. Clyde Biosciences Limited
• 29. Eurofins Scientific SE
• 30. ICON PLC
• 31. Celerion